145 related articles for article (PubMed ID: 38691888)
1. Update on the development of TGR5 agonists for human diseases.
Jin W; Zheng M; Chen Y; Xiong H
Eur J Med Chem; 2024 May; 271():116462. PubMed ID: 38691888
[TBL] [Abstract][Full Text] [Related]
2. TGR5 agonists for diabetes treatment: a patent review and clinical advancements (2012-present).
Bhimanwar RS; Mittal A
Expert Opin Ther Pat; 2022 Feb; 32(2):191-209. PubMed ID: 34652989
[TBL] [Abstract][Full Text] [Related]
3. Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5).
Chen T; Reich NW; Bell N; Finn PD; Rodriguez D; Kohler J; Kozuka K; He L; Spencer AG; Charmot D; Navre M; Carreras CW; Koo-McCoy S; Tabora J; Caldwell JS; Jacobs JW; Lewis JG
J Med Chem; 2018 Sep; 61(17):7589-7613. PubMed ID: 30141927
[TBL] [Abstract][Full Text] [Related]
4. Design of G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) soft drugs with reduced gallbladder-filling effects.
Han F; Ning M; Cao H; Ye Y; Feng Y; Leng Y; Shen J
Eur J Med Chem; 2020 Oct; 203():112619. PubMed ID: 32682201
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of the bile acid receptor TGR5 in metabolism.
van Nierop FS; Scheltema MJ; Eggink HM; Pols TW; Sonne DP; Knop FK; Soeters MR
Lancet Diabetes Endocrinol; 2017 Mar; 5(3):224-233. PubMed ID: 27639537
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway.
Yusta B; Matthews D; Flock GB; Ussher JR; Lavoie B; Mawe GM; Drucker DJ
Mol Metab; 2017 Jun; 6(6):503-511. PubMed ID: 28580281
[TBL] [Abstract][Full Text] [Related]
7. Patented TGR5 modulators: a review (2006 - present).
Gioiello A; Rosatelli E; Nuti R; Macchiarulo A; Pellicciari R
Expert Opin Ther Pat; 2012 Dec; 22(12):1399-414. PubMed ID: 23039746
[TBL] [Abstract][Full Text] [Related]
8. The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders.
Stepanov V; Stankov K; Mikov M
J Recept Signal Transduct Res; 2013 Aug; 33(4):213-23. PubMed ID: 23782454
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?
Hodge RJ; Nunez DJ
Diabetes Obes Metab; 2016 May; 18(5):439-43. PubMed ID: 26818602
[TBL] [Abstract][Full Text] [Related]
10. TGR5, Not Only a Metabolic Regulator.
Guo C; Chen WD; Wang YD
Front Physiol; 2016; 7():646. PubMed ID: 28082913
[TBL] [Abstract][Full Text] [Related]
11. Compound and compositions as TGR5 agonists: WO2012082947.
Raval S
Expert Opin Ther Pat; 2013 Apr; 23(4):531-6. PubMed ID: 23409864
[TBL] [Abstract][Full Text] [Related]
12. The discovery of 12β-methyl-17-epi-18-nor-bile acids as potent and selective TGR5 agonists.
Luxenburger A; Harris LD; Ure EM; Jiao W; Woolhouse AD; Cameron SA; Weymouth-Wilson A; Furneaux RH; Pitman JL; Hinkley SFR
Eur J Med Chem; 2023 Mar; 250():115143. PubMed ID: 36841086
[TBL] [Abstract][Full Text] [Related]
13. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
[TBL] [Abstract][Full Text] [Related]
14. Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.
Jadhav K; Xu Y; Xu Y; Li Y; Xu J; Zhu Y; Adorini L; Lee YK; Kasumov T; Yin L; Zhang Y
Mol Metab; 2018 Mar; 9():131-140. PubMed ID: 29361497
[TBL] [Abstract][Full Text] [Related]
15. Chemical exploration of TGR5 functional hot-spots: Synthesis and structure-activity relationships of C7- and C23-Substituted cholic acid derivatives.
Rosatelli E; Carotti A; Cerra B; De Franco F; Passeri D; Pellicciari R; Gioiello A
Eur J Med Chem; 2023 Dec; 261():115851. PubMed ID: 37813065
[TBL] [Abstract][Full Text] [Related]
16. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.
Sato H; Macchiarulo A; Thomas C; Gioiello A; Une M; Hofmann AF; Saladin R; Schoonjans K; Pellicciari R; Auwerx J
J Med Chem; 2008 Mar; 51(6):1831-41. PubMed ID: 18307294
[TBL] [Abstract][Full Text] [Related]
17. The bile acid TGR5 membrane receptor: from basic research to clinical application.
Duboc H; Taché Y; Hofmann AF
Dig Liver Dis; 2014 Apr; 46(4):302-12. PubMed ID: 24411485
[TBL] [Abstract][Full Text] [Related]
18. A Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic β-Cells in Type 2 Diabetic Mice.
Zheng C; Zhou W; Wang T; You P; Zhao Y; Yang Y; Wang X; Luo J; Chen Y; Liu M; Chen H
PLoS One; 2015; 10(7):e0134051. PubMed ID: 26208278
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity.
Pellicciari R; Gioiello A; Macchiarulo A; Thomas C; Rosatelli E; Natalini B; Sardella R; Pruzanski M; Roda A; Pastorini E; Schoonjans K; Auwerx J
J Med Chem; 2009 Dec; 52(24):7958-61. PubMed ID: 20014870
[TBL] [Abstract][Full Text] [Related]
20. The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling.
Li T; Holmstrom SR; Kir S; Umetani M; Schmidt DR; Kliewer SA; Mangelsdorf DJ
Mol Endocrinol; 2011 Jun; 25(6):1066-71. PubMed ID: 21454404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
